Supply of Roche A1C Diagnostic Test Reagents

The contract entails the supply of 1,000 units of Roche A1C test reagents designed for use with Roche Cobas Pros instruments in clinical laboratory settings. These reagents are intended for hemoglobin A1C testing, a critical diagnostic tool for monitoring long-term blood glucose levels in patients with diabetes. The agreement is structured as a subcontract under the Department of Veterans Affairs, specifically managed by the 250-NETWORK Contract Office 10, and falls under the NAICS code 325414, which corresponds to pharmaceutical and medicine manufacturing. The solicitation was posted on April 30, 2026, and while no set-aside classification or place of performance details are provided, the procurement is focused on ensuring reliable, high-volume diagnostic capacity for VA healthcare facilities. The contract supports essential medical testing infrastructure without specifying delivery timelines, payment terms, or warranty conditions beyond the scope of supply.